296 results on '"Berghoff, Anna Sophie"'
Search Results
2. Neurofibromatose Typ 1: Vorsorgebogen für Kinder und Jugendliche in Österreich: Konsensuspapier des österreichischen NF-Netzwerks
3. DNA Methylation Signatures Correlate with Response to Immune Checkpoint Inhibitors in Metastatic Melanoma
4. Publisher Erratum: Neurofibromatose Typ 1: Vorsorgebogen für Kinder und Jugendliche in Österreich
5. Immune cell distribution and DNA methylation signatures differ between tumor and stroma enriched compartment in pancreatic ductal adenocarcinoma
6. Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer
7. Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
8. Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature
9. Current Treatment Strategies in Breast Cancer Brain Metastases
10. Brain metastases: new systemic treatment approaches
11. Viennese risk prediction score for Advanced Gastroesophageal carcinoma based on Alarm Symptoms (VAGAS score): characterisation of alarm symptoms in advanced gastro-oesophageal cancer and its correlation with outcome
12. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic
13. Publisher Correction: Brain metastases: new systemic treatment approaches
14. New emerging targets in cancer immunotherapy: the role of Cluster of Differentiation 40 (CD40/TNFR5)
15. New targeted therapies/small molecules in oncology and hematology
16. Supplementary Table S2 from Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer
17. Data from Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer
18. Supplementary Figure S2 from Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer
19. Current Treatment Strategies in Breast Cancer Brain Metastases
20. Diagnostic value of 18F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site
21. Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p
22. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis
23. Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer
24. Young oncologists’ perspective on the role and future of the clinician-scientist in oncology
25. Direct image to subtype prediction for brain tumors using deep learning
26. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer
27. Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC)
28. BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis
29. DNA Methylation Associates With Clinical Courses of Atypical Meningiomas: A Matched Case–Control Study
30. DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma
31. Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues
32. New Approaches with Precision Medicine in Adult Brain Tumors
33. EVI1 Promotes the Proliferation and Invasive Properties of Human Head and Neck Squamous Cell Carcinoma Cells
34. Focal radiotherapy of brain metastases in combination with immunotherapy and targeted drug therapy
35. αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer
36. microRNA Expression Pattern Modulates Temozolomide Response in GBM Tumors with Cancer Stem Cells
37. AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry
38. Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature
39. Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases
40. Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens
41. Characterization of the inflammatory response to solid cancer metastases in the human brain
42. Systemic and local inflammation characteristics in patients with cancer after lung transplantation.
43. Focal Radiotherapy of Brain Metastases in Combination With Immunotherapy and Targeted Drug Therapy
44. EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours
45. Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases
46. Brain metastases: pathobiology and emerging targeted therapies
47. ALK gene aberrations and the JUN/JUNB/PDGFR axis in metastatic NSCLC
48. Frequent overexpression of ErbB – receptor family members in brain metastases of non-small cell lung cancer patients
49. Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) are Associated with a High Risk of Venous Thromboembolism in Patients with Glioma
50. Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.